Literature DB >> 17704730

Early organ-specific endothelial activation during hemorrhagic shock and resuscitation.

Matijs van Meurs1, Francis M Wulfert, Ageeth J Knol, Ann De Haes, Martin Houwertjes, Leon P H J Aarts, Grietje Molema.   

Abstract

Multiple organ dysfunction syndrome (MODS) is a complication of hemorrhagic shock (HS) and related to high morbidity and mortality. Interaction of activated neutrophils and endothelial cells is considered to play a prominent role in the pathophysiology of MODS. Insight in the nature and molecular basis of endothelial cell activation during HS can assist in identifying new rational targets for early therapeutic intervention. In this study, we examined the kinetics and organ specificity of endothelial cell activation in a mouse model of HS. Anesthetized male mice were subjected to controlled hemorrhage to a MAP of 30 mmHg. Mice were killed after 15, 30, 60, or 90 min of HS. After 90 min of hemorrhagic shock, a group of mice was resuscitated with 6% hydroxyethyl starch 130/0.4. Untreated mice and sham shock mice that underwent instrumentation and 90 min of anesthesia without shock served as controls. Gene expression levels of inflammatory endothelial cell activation (P-selectin, E-selectin, vascular cell adhesion molecule 1, and intercellular adhesion molecule 1) and hypoxia-responsive genes (vascular endothelial growth factor and hypoxia-inducible factor 1alpha) were quantified in kidney, liver, lung, brain, and heart tissue by quantitative reverse-transcription-polymerase chain reaction. Furthermore, we examined a selection of these genes with regard to protein expression and localization using immunohistochemical analysis. Induction of inflammatory genes occurred early during HS and already before resuscitation. Expression of adhesion molecules was significantly induced in all organs, albeit to a different extent depending on the organ. Endothelial genes CD31 and VE-cadherin, which function in endothelial cell homeostasis and integrity, were not affected during the shock phase except for VE-cadherin in the liver, which showed increased mRNA levels. The rapid inflammatory activation was not paralleled by induction of hypoxia-responsive genes. This study demonstrated the occurrence of early and organ-specific endothelial cell activation during hemorrhagic shock, as presented by induced expression of inflammatory genes. This implies that early therapeutic intervention at the microvascular level may be a rational strategy to attenuate MODS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17704730     DOI: 10.1097/SHK.0b013e318145a7c1

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  24 in total

1.  Melanocortins protect against multiple organ dysfunction syndrome in mice.

Authors:  Alessandra Bitto; Francesca Polito; Domenica Altavilla; Natasha Irrera; Daniela Giuliani; Alessandra Ottani; Letteria Minutoli; Luca Spaccapelo; Maria Galantucci; Renzo Lodi; Giuseppe Guzzo; Salvatore Guarini; Francesco Squadrito
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Pulmonary endothelial cell activation during experimental acute kidney injury.

Authors:  Carolyn M Feltes; Heitham T Hassoun; Mihaela L Lie; Chris Cheadle; Hamid Rabb
Journal:  Shock       Date:  2011-08       Impact factor: 3.454

3.  Macrophage-derived chemokine (CCL22) is a novel mediator of lung inflammation following hemorrhage and resuscitation.

Authors:  Jillian R Richter; Jeffrey M Sutton; Ritha M Belizaire; Lou Ann Friend; Rebecca M Schuster; Taylor A Johannigman; Steven G Miller; Alex B Lentsch; Timothy A Pritts
Journal:  Shock       Date:  2014-12       Impact factor: 3.454

4.  CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.

Authors:  Jan Schulte Am Esch; Simon C Robson; Moritz Schmelzle; Constanze Duhme; Wolfgang Junger; Steven D Salhanick; Yu Chen; Yan Wu; Vasilis Toxavidis; Eva Csizmadia; Lihui Han; Shu Bian; Günter Fürst; Martina Nowak; Seth J Karp; Wolfram T Knoefel
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

5.  Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2.

Authors:  Yuehua Li; Meng Xiang; Youzhong Yuan; Guozhi Xiao; Jian Zhang; Yong Jiang; Yoram Vodovotz; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-14       Impact factor: 3.619

6.  Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injury.

Authors:  Ibrahim Nassour; Benjamin Kautza; Mark Rubin; Daniel Escobar; Jason Luciano; Patricia Loughran; Hernando Gomez; Jeffrey Scott; David Gallo; John Brumfield; Leo E Otterbein; Brian S Zuckerbraun
Journal:  Shock       Date:  2015-02       Impact factor: 3.454

7.  The flow dependency of Tie2 expression in endotoxemia.

Authors:  Neng F Kurniati; Rianne M Jongman; Franziska vom Hagen; Katherine C Spokes; Jill Moser; Erzsébet Ravasz Regan; Guido Krenning; Jan-Renier A J Moonen; Martin C Harmsen; Michel M R F Struys; Hans-Peter Hammes; Jan G Zijlstra; William C Aird; Peter Heeringa; Grietje Molema; Matijs van Meurs
Journal:  Intensive Care Med       Date:  2013-04-06       Impact factor: 17.440

8.  Pancreatic digestive enzyme blockade in the small intestine prevents insulin resistance in hemorrhagic shock.

Authors:  Frank A DeLano; Geert W Schmid-Schönbein
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

9.  IFNγ and TNFα mediate CCL22/MDC production in alveolar macrophages after hemorrhage and resuscitation.

Authors:  Nadine Beckmann; Jeffrey M Sutton; Richard S Hoehn; Peter L Jernigan; Lou Ann Friend; Taylor A Johanningman; Rebecca M Schuster; Alex B Lentsch; Charles C Caldwell; Timothy A Pritts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-26       Impact factor: 5.464

Review 10.  Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target?

Authors:  Matijs van Meurs; Philipp Kümpers; Jack J M Ligtenberg; John H J M Meertens; Grietje Molema; Jan G Zijlstra
Journal:  Crit Care       Date:  2009-03-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.